LIPIVIN-CA

bt_bb_section_bottom_section_coverage_image
https://www.larivinpharma.com/wp-content/uploads/2024/04/LIPIVIN-CA.jpg

Composition

  • Rosuvastatin 10 mg
  • Clopidogrel 75 mg
  • Aspirin 75 mg

Description:
Lipivin-CA is a synergistic combination of three powerful medications designed to manage cardiovascular conditions effectively. This formulation combines Rosuvastatin, Clopidogrel, and Aspirin to offer comprehensive support for heart health.

Indications:
Lipivin-CA is prescribed for:

  • Prevention of cardiovascular events in patients with a history of coronary artery disease (CAD).
  • Reduction of the risk of myocardial infarction and stroke.
  • Management of dyslipidemia in conjunction with other therapeutic interventions.

Mechanism of Action:

  • Rosuvastatin: A statin that works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thus lowering LDL cholesterol and triglycerides while increasing HDL cholesterol.
  • Clopidogrel: An antiplatelet agent that inhibits platelet aggregation by blocking the P2Y12 ADP receptor on platelets, thereby reducing the risk of thrombotic events.
  • Aspirin: An anti-inflammatory and antiplatelet agent that inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 production and decreasing platelet aggregation, which helps prevent blood clots.

Dosage and Administration:

  • The recommended dose of Lipivin-CA is one capsule daily, preferably taken in the morning with or without food.
  • Dosage adjustments may be necessary based on the individual patient’s condition and response to therapy.

Contraindications:

  • Hypersensitivity to any of the components of the formulation.
  • Active bleeding or a history of bleeding disorders.
  • Severe liver impairment or active liver disease.
  • Pregnant or breastfeeding women.

Warnings and Precautions:

  • Regular monitoring of liver function tests is advised due to the presence of Rosuvastatin.
  • Caution is required in patients with a history of gastrointestinal bleeding or ulcer disease.
  • Discontinue use and seek medical attention if signs of bleeding or severe allergic reactions occur.

Side Effects:
Common side effects may include:

  • Headache
  • Gastrointestinal discomfort
  • Dizziness
  • Muscle pain or weakness

Serious side effects, although rare, include:

  • Liver enzyme abnormalities
  • Severe bleeding
  • Allergic reactions

Drug Interactions:

  • Use with caution in combination with other anticoagulants or antiplatelet agents.
  • May interact with certain medications such as cyclosporine, fibrates, or other statins.

Storage:

  • Store in a cool, dry place, away from direct sunlight.
  • Keep out of reach of children.

Packaging:

  • Available in blister packs of 10 capsules.

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/LIPIVIN-CA.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved